Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Dec 18.
Published in final edited form as: J Org Chem. 2020 Aug 5;85(24):16218–16225. doi: 10.1021/acs.joc.0c01041

Mild Cu(OTf)2-mediated C-glycosylation with Chelation-Assisted Picolinate as a Leaving Group

Wenjing Ye a,†,#, Christopher M Stevens a,#, Peng Wen a,#, Christopher J Simmons a,b, Weiping Tang a,b
PMCID: PMC8138965  NIHMSID: NIHMS1700138  PMID: 32691596

Abstract

C-glycosylation reactions of glycosyl picolinates with allyltrimethylsilane or silyl enol ethers were developed. Picolinate as a chelation-assisted leaving group could be activated by Cu(OTf)2 and avoided the use of harsh Lewis acids. The glycosylations were operated under mild neutral conditions and gave the corresponding C-glycosides in up to 95% yield with moderate to excellent stereoselectivities.

Graphical Abstract

graphic file with name nihms-1700138-f0006.jpg


Glycosylation is arguably the most important reaction in carbohydrate chemistry and numerous glycosylation protocols have been developed for the synthesis of glycosides.1 Compared with O-glycosides, which are susceptible to enzymatic degradation, C-glycosides have attracted widespread attention due to their higher stability to glycosidases and hydrolases.2 For example, The C-glycoside analogue 1 of KRN7000 showed more effective activity than the corresponding O-glycoside.3 Glycoconjugate 2 of genistein exhibited higher antiproliferative potential than the parent compound.4 Various natural products also bear C-glycosidic units, such as (+)-varitriol5 and (+)-ambruticin S (Figure 1).6 However, among the diverse glycosylation methods, O-glycosylations occupy a large majority, and C-glycosylations are comparatively less.2 There have been various reported methods for the formation of C-glycosides, including transition metal catalysis and other catalyst systems,7 Knoevenagel condensations,8 and direct nucelophilic substitutions.9 While these reactions are efficient, they are limited in scope of products and tend to rely on harsh reaction conditions. Considering the C-glycosides as biologically significant molecules, prevalent to many natural products, and hydrolytically stable surrogates of native O-glycosides, it is necessary to develop efficient and stereoselective C-glycosylation methods under mild conditions for satisfying the demands of C-glycoside diversity. Of particular interest is the development of high-yielding and low-cost methods that can be run under mild conditions that are compatible to a variety of functional groups.

Figure 1.

Figure 1.

Bioactive and Natural C-Glycosides.

Another consideration in the synthesis of C-glycosides are the leaving group. Many leaving groups have been utilized in the past with great successes, such as glycals, glycal halides, thioglycosides, lactols, and acetals.10 The most common leaving group utilized, however, is the acetyl group and other ester-derivatives, because they are readily available.11 While the acetyl group has been used effectively as a donor to produce high yields in short time frames, it requires promotion by air- and moisture-sensitive Lewis acids which introduces limitations in the reaction scope and feasibility. Therefore, it is highly desirable to have a proper leaving group that does not require these strong acids for activation while maintaining the high yields.

Recently, we developed an efficient mild O-glycosylation method using isoquinoline-1-carboxylate as a leaving group (Scheme 1),12 which is advantageous over the previously reported picolinate,13 by minimizing the transesterification byproducts. Using Cu(OTf)2 as a mediator for remote activation,14 the isoquinoline ester can be removed to give an oxocarbenium ion intermediate, which subsequently leads to O-glycosides with high yields under mild neutral conditions. This chelation-assisted approach shows promise in preliminary application to the synthesis of C-glycosides as the isoquinoline carboxylate and picolinate leaving groups become traceless leaving groups through two-point chelation to the copper ion. Based on these results, we envision that various C-glycosides can also be prepared under mild and neutral conditions using the same type of leaving group, giving advantages over the previous methods that use the acetyl leaving group.

Scheme 1.

Scheme 1.

Glycosylation with isoquinoline carboxylate or picolinate as a leaving group.

Allylic group is a useful building block and it allows many further transformations due to the versatile terminal olefin functional group. For example, the aforementioned bioactive and natural molecules can be accessed through olefin metathesis of allyl glycosides with the suitable alkenes (Figure 1). The introductions of anomeric allyl saccharides were generally promoted by Lewis acid-activated glycosylations.15 They usually stereoselectively gave α-allyl glycosides in excellent yield. However, air- and moisture-sensitive Lewis acids, such as BF3·Et2O, TMSOTf, etc. were needed. Recently, the Yu group accomplished C-glycosylation of glycosyl ortho-alkynylbenzoates with allyltrimethylsilane or silyl enol ethers in high yields and stereoselectivities where a milder Lewis acid Ph3PAuNTf2 was used.16 Sulfoxide, sulfonates, and hydroxybenzotriazolyl groups were also employed as leaving groups for improving the yields and stereoselectivities.17 It was also reported that allylation of benzylidene protected glucose and mannose could highly stereoselectively give α- and β-C-glycosides, respectively.18 Herein, we chose highly nucleophilic and easily functionalized allyl and silyl enol ethers as the glycosyl acceptor, stable picolinates as the donors, and the mild Lewis acid Cu(OTf)2 as the mediator to explore C-glycosylation.

First, benzyl-protected galactosyl isoquinoline carboxylate 5a and picolinate 5b were used as the glycosyl donors to optimize the reaction conditions (Table 1). Using Cu(OTf)2 as the mediator and CH2Cl2 as the solvent, the reaction of 5a with allyl TMS gave the corresponding allyl α-C-glycoside 7a in 42% yield (entry 1). Additionally, trace amounts of allyl β-C-glycoside was observed by TLC analysis. When the amount of allyl TMS was increased to 6.0 equiv, the yield of 7a was improved to 82% (entry 2). Under the same conditions, we compared the results of the glycosylation of benzyl-protected galactosyl picolinate 5b with those of 5a. In our previous work,12 O-glycosylation of glycosyl isoquinoline carboxylates showed better results than picolinates because the nucleophilic attack of the ester carbonyl group by the alcohol nucleophile in the former was inhibited. We later found that picolinates and isoquinoline carboxylates behaved similarly during the preparation of glycosyl halides, because halides preferentially reacted with the anomeric carbon over the carbonyl ester.19 In the case of C-glycosylation, picolinate 5b (entries 3 and 4) is slightly better than isoquinoline carboxylate 5a (entries 1 and 2). α-C-Glycoside 7a can be prepared in 95% yield with 6.0 equiv allyl TMS (entry 4). The total yield of α- and β-anomers was 99% and the ratio of α and β anomers was more than 20:1. When the solvent was changed from CH2Cl2 to Et2O or CH3CN, no more than an 18% yield of allyl α-C-glycoside 7a was obtained (entries 5 and 6). For Et2O, little of the starting material was consumed, indicating that the low yield is likely due to solubility issues with Cu(OTf)2. For CH3CN, most of the starting material was consumed in the reaction. Disappointingly, the C-glycosylation of disarmed donors 5c and 5d did not give the desired allyl C-glycosides. The reaction of perbenzoyl galactosyl isoquinoline carboxylate 5c with allyl TMS gave a complex mixture and only trace amounts of desired product was observed, while the reaction of less reactive 5d gave trace amounts of products and most of 5d was recovered (entries 7 and 8). This may be attributed to the high activation energy barriers of disarmed saccharides, and the weaker nucleophilicity of allyl TMS compared to O-nucleophiles.20

Table 1.

Optimizing C-glycosylation of galactopyranosyl isoquinoline carboxylate (IQC) and picolinate (Pico) with allyltrimethylsilane.a

graphic file with name nihms-1700138-t0007.jpg
Entry Donor Solvent Yield of 7a or 7bc)
1 graphic file with name nihms-1700138-t0008.jpg CH2Cl2 42%
2b) CH2Cl2 82%
3 graphic file with name nihms-1700138-t0009.jpg CH2Cl2 46%
4b) CH2Cl2 95% (99%)d)
5 Et2O trace
6 CH3CN 18%
7b) graphic file with name nihms-1700138-t0010.jpg CH2Cl2 complicated
8b) graphic file with name nihms-1700138-t0011.jpg CH2Cl2 trace
a)

Conditions: 5 (0.1 mmol), allyl TMS (2.0 eq.), Cu(OTf)2 (1.2 eq.), 4A MS (100 mg), solvent (0.5 mL), rt, Ar, 24 h;

b)

allyl TMS (6.0 eq.);

c)

Isolated yields;

d)

Total yield of α- and β-anomers, α/β > 20:1.

Considering the slightly better performance of the picolinate donor for C-glycosylation and the lower price of picolinic acid than that of isoquinoline carboxylic acid, glycosyl picolinates were selected as donors for testing the scope of the Cu(OTf)2-mediated C-glycosylation (Scheme 2). Most of the armed monosaccharides and disaccharides demonstrated expected reactivity and the corresponding allyl C-glycosides were obtained in moderate to excellent yields. The reaction of perbenzyl glucosyl picolinate 5e with allyl TMS gave an excellent result and produced the corresponding allyl C-glucoside α-7e in 90% yield. A small amount of β anomer was also collected and the ratio of α and β anomers was more than 20:1. Similar results were obtained when the reaction was scaled up to 1 mmol, which afforded 7e in 86% yield with a 15:1 α/β ratio. Using perbenzyl mannosyl picolinate 5f as the donor, the reaction gave 7f in 98% total yield with the α/β ratio of 10:1. The allylation of xylosyl picolinate 5g led to the allyl C-glycoside α-7g in 74% yield and the ratio of α and β anomers was also 10:1. C-glycosylation of Bn-protected L-fucosyl picolinate 5h similarly gave α-allyl product 7h in 65% yield with a α/β ratio of 20:1.

Scheme 2.

Scheme 2.

Cu(OTf)2-mediated C-Glycosylation with allyl TMS as an acceptor. a) Condition A: 5 (0.1 mmol), allyl TMS (6.0 equiv), Cu(OTf)2 (1.2 equiv), 4A MS (100 mg), CH2Cl2 (0.5 mL), rt, Ar, 16 h; b) Condition B: 5 (0.1 mmol), allyl TMS (6.0 equiv), Cu(OTf)2 (1.2 equiv), CH2Cl2 (0.5 mL), rt, Ar, 16 h, toluene was used as azeotrope to remove water; c) The yield is the combined of α and β; d) 1 mmol reaction

Using the present allylation protocol, allyl 2-deoxy glycosides were successfully prepared. The allylation of 5i and 5j exclusively gave α anomers 7i and 7j in 53% and 68% yields, respectively. Exclusive allyl C-glycoside α-7k was obtained in 59% yield for the perbenzyl ribosyl picolinate 5k substrate. For these perbenzyl monosaccharide substrates, the allylation showed high α selectivity, which could be well explained through the conformational preferences of the oxocarbenium ion intermediate, as well as consideration of steric effects that developed in the transition states for nucleophilic attack.20 C-glycosylation with benzylidene protected glucosyl picolinate 5l and mannosyl picolinate 5m donors were also tested. Allyl C-glycosides α-7l and α-7m were acquired in 81% and 53% yields, respectively. The stereoselectivities of these two reactions were coherent with the allylation of thioglycosides reported in the literature.18 The ratio of 20:1 for 7l and exclusive α for 7m were obtained. C-glycosylation of disaccharide donor 5n was also explored, giving the corresponding allyl C-glycoside α-7n in 69% yield with a α/β ratio of 8:1.

Using Cu(OTf)2 as the mediator and CH2Cl2 as the solvent, the reactions of several more disarmed glycosyl donors with allyl TMS were investigated. Disappointingly, no desired allyl C-glycosides were obtained. The reaction of acetyl- or pivaloyl glucosyl picolinate with allyl TMS showed most of the starting material remained after the reaction. Hydrolysis products were collected for perbenzoyl ribosyl and perbenzoyl fucosyl picolinate substrates. The reaction of perbenzoyl-protected xylosyl picolinate 5o gave a glycal product 7o in 68% yield without the desired C-glycoside found (Scheme 3).

Scheme 3.

Scheme 3.

Reaction of disarmed saccharide with allyl TMS.

Silyl enol ethers are highly versatile coupling reagents for constructing C-C bonds.21 C-glycosylations of picolinate donors with nucleophilic silyl enol ethers were therefore explored (Scheme 4). Aromatic silyl enol ether 8a and aliphatic silyl enol ether 8b were used as acceptors to investigate the reactivity and selectivity of the glycosylations. Generally, C-glycosylations with silyl enol ethers showed less stereoselectivities than those with allyl TMS as the acceptor. With 1.2 equiv Cu(OTf)2 as the promoter, the reaction of perbenzyl galactopyranosyl donor 5b with 1-styrenyloxytrimethylsilane 8a (1.5 equiv) produced the corresponding C-glycoside 9a in 93% total yield with the stereoselectivity of 2.7:1. Exclusive α C-glycoside 9b was obtained in 90% yield for the glycosylation of glucosyl donor 5e. Again, the scalability of the reaction was demonstrated by performing the same reaction on 1 mmol scale, with 9b isolated in 88% yield as a single anomer. Mannosyl C-glycoside 9c was prepared as a 1.7:1 mixture of anomers in 98% total yield. The reactions of benzylidene-protected glucosyl donor 5l and mannosyl donor 5m with 8a gave similar results to the previous allylations, but showed lower stereoselectivities. The glycosylations of 5l and 5m led to the corresponding C-glycosides 9d and 9e in 78% and 51% total yields with α/β ratios of 7:1 and 1:13, respectively. The C-glycosylations with 1-tert-butylvinyloxytrimethylsilane 8b provided the corresponding 2-carbonyl C-glycosides 9f and 9g in 92% and 87% yield with α/β ratios of 4.5:1 and >20:1, respectively, which were similar to the results of acceptor 8a.

Scheme 4.

Scheme 4.

Cu(OTf)2-mediated C-Glycosylation with silyl enol ether as an acceptor. a) Reaction conditions: 5 (0.1 mmol), silyl enol ether (1.5 equiv), Cu(OTf)2 (1.2 equiv), 4A MS (100 mg), CH2Cl2 (0.5 mL), rt, Ar, 16 h. The yield is the combined of α and β; b) 1 mmol reaction scale.

In conclusion, both picolinates and isoquinoline carboxylates are convenient leaving groups for glycosylations, but the former is more suitable for C-glycosylations. With Cu(OTf)2 as a mediator, C-glycosylations of stable glycosyl picolinate donors with allyltrimethylsilane or silyl enol ethers were explored. The allylations of various armed glycosyl picolinates offered the corresponding C-glycosides in up to 95% yield with excellent stereoselectivities. The reactions abided by the oxocarbenium ion intermediate mechanism reported previously.18,20 Disarmed saccharides could not produce the desired allyl C-glycosides due to low reactivity. The glycosylations of armed glycosyl picolinates with silyl enol ethers exhibited good reactivities but moderate stereoselectivities, except for the reaction of perbenzyl glucosyl picolinate which exclusively gave α-C-glycoside.

An added benefit of the method reported here over those previously reported is the use of a relatively cheap copper salt. This decrease in cost while maintaining relatively good yields, increases the synthetic efficacy. The use of a picolinate ester as the glycosyl donor brings added benefits, as they are easily prepared from commercially available picolinic acid and can be cleaved under mostly neutral conditions. Picolinic acid is also much cheaper than reagents involved for the formation of many other glycosyl donors including the tested isoquinoline-1-carboxylic acid. The above results show that the stable picolinate group could be a good glycosyl donor to efficiently synthesize useful C-glycosides under mild reaction conditions.

EXPERIMENTAL SECTION

All reactions in non-aqueous media were conducted under a positive pressure of dry argon in glassware that had been dried in oven prior to use unless noted otherwise. Anhydrous solutions of reaction mixtures were transferred via an oven dried syringe or cannula. All solvents were dried prior to use unless noted otherwise. Starting materials were azeotroped with dry toluene three times the day before use. Thin layer chromatography was performed using precoated silica gel plates. Flash column chromatography was performed with silica gel (40-63 μm). Infrared spectra (IR) were obtained on a Bruker Equinox 55 Spectrophotometer. 1H and 13C nuclear magnetic resonance spectra (NMR) were obtained on a Varian Unity-Inova 400 MHz or 500 MHz recorded in ppm (δ) downfield of TMS (δ = 0) in CDCl3 unless noted otherwise. Signal splitting patterns were described as singlet (s), doublet (d), triplet (t), quartet (q), quintet (quint), or multiplet (m), with coupling constants (J) in hertz. High resolution mass spectra (HRMS) were performed by Analytical Instrument Center at the School of Pharmacy or Department of Chemistry on an Electron Spray Injection (ESI) mass spectrometer.

General procedure for the synthesis of silyl enol ether.

Silyl enol ether 8a22 and 8b23 were prepared and characterized according to the literature methods and their spectra were in accordance with the literature.

Synthesis and characterization of isoquinoline and picolinic glycosyl donors.

All isoquinoline and picolinic glycosyl donors not otherwise specified below were prepared and characterized in accordance with previous literature.19

5a: 2,3,4,6-Tetra-O-benzyl-α-d-galactopyranosyl isoquinoline-1-carboxylate.

To an oven-dried flask was added commercially available 2,3,4,6-tetra-O-benzyl-α-d-galactopyranose (1.00 mmol, 540.7 mg), DMAP (0.20 mmol, 24.4 mg), 1-isoquinolinecarboxylic acid (ISQ-COOH) (1.30 mmol, 225.2 mg), EDCI (2.00 mmol, 383.3 mg) and dry DCM (5.0 mL) under Ar. The reaction was stirred at RT and monitored by TLC. After the reaction was completed (~12 h), the solvent was removed under vacuum and the residue was purified by flash column chromatography (eluent: Hex:EA=5:1, V/V) to afford 5a (white solid, 650.0 mg, 94% yield). M.P.: 100-102 °C. Optical rotation: [α]D21 = +7.32 (c 0.205, CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.68 (d, J = 8.7 Hz, 1H), 8.63 (d, J = 5.5 Hz, 1H), 7.88 (d, J = 8.3 Hz, 1H), 7.82 (d, J = 5.5 Hz, 1H), 7.72 (t, J = 7.6 Hz, 1H), 7.58 (t, J = 7.8 Hz, 1H), 7.32 (m, 17H), 7.19-7.08 (m, 3H), 5.99 (d, J = 8.0 Hz, 1H), 5.03-4.93 (m, 2H), 4.86 (d, J = 10.9 Hz, 1H), 4.78 (s, 2H), 4.62 (d, J = 11.4 Hz, 1H), 4.47 (q, J = 11.8 Hz, 2H), 4.21 (t, J = 8.9 Hz, 1H), 4.04 (d, J = 2.8 Hz, 1H), 3.86 (t, J = 6.6 Hz, 1H), 3.78-3.58 (m, 3H). 13C{1H}NMR (101 MHz, CDCl3) δ 164.6, 148.2, 141.8, 138.6, 138.4, 138.3, 137.8, 136.8, 130.5, 128.7, 128.4, 128.4, 128.2, 128.1, 128.1, 128.0, 127.8, 127.7, 127.6, 127.5, 127.4, 127.1, 126.8, 126.3, 124.1, 95.8, 82.3, 78.1, 77.2, 75.3, 74.8, 74.5, 73.6, 72.9, 68.1. HRMS (ESI) for C44H41NO7 (M+H), 696.2956 (Calc.), found 696.2951. IR (neat): ν 1743, 1454, 1366, 1215, 1099, 1028, 745, 698, 997.

5j: 3,4,6-Tri-O-benzyl-2-deoxy-d-galactopyranosyl picolinate.

To an oven-dried flask was added commercially available 3,4,6-tri-O-benzyl-2-deoxy- d-galactopyranose (1.00 mmol, 434.5 mg), DMAP (0.20 mmol, 24.4 mg), picolinate acid (1.30 mmol, 160.0 mg), EDCI (2.00 mmol, 383.3 mg) and dry DCM (5.0 mL) under Ar. The reaction was stirred at RT and monitored by TLC. After the reaction was completed (~12 h), the solvent was removed under vacuum and the residue was purified by flash column chromatography (eluent: Hex:EA=2:1, V/V) to afford 5j (α:β=2.3:1, colorless syrup, 420.0 mg, 80% yield). Reported as mixture of anomers, ratio identified through 1H NMR spectroscopy. Optical rotation: [α]D21 = +35.3 (c 0.575, CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.79 – 8.74 (m, 2H), 8.13 (d, J = 7.8 Hz, 1H), 7.98 (d, J = 7.9 Hz, 1H), 7.84 – 7.77 (m, 2H), 7.45 (m, 2H), 7.39 – 7.21 (m, 30H), 6.58 (d, J = 3.2 Hz, 1H), 5.98 (dd, J = 10.1, 2.4 Hz, 1H), 5.01 – 4.92 (m, 2H), 4.72 – 4.58 (m, 6H), 4.54 – 4.37 (m, 4H), 4.23 – 4.05 (m, 4H), 3.93 (d, J = 2.4 Hz, 2H), 3.81 – 3.52 (m, 4H), 2.61 – 2.37 (m, 2H), 2.31 – 2.16 (m, 2H). 13C{1H}NMR (101 MHz, CDCl3) δ 163.5, 163.1, 150.2, 150.1, 147.9, 147.3, 138.8, 138.7, 138.2, 138.1, 137.9, 137.9, 137.0, 137.0, 129.8, 129.7, 129.7, 128.5, 128.5, 128.5, 128.4, 128.4, 128.4, 128.4, 128.3, 128.2, 128.2, 128.1, 128.0, 128.0, 128.0, 127.9, 127.9, 127.8, 127.8, 127.8, 127.7, 127.6, 127.6, 127.5, 127.4, 127.2, 127.1, 125.7, 125.3, 94.6, 93.8, 75.0, 74.5, 74.5, 74.0, 73.6, 73.6, 72.8, 72.6, 71.6, 70.5, 70.5, 68.8, 68.6, 31.5, 30.2. HRMS (ESI) for C33H33NO6 (M+Na), 562.2200 (Calc.), found 562.2201. IR (neat): ν 1727, 1644, 1585, 1496, 1454, 1438, 1361, 1304, 1279, 1245, 1201, 1146, 1097, 1044, 1026, 992, 891, 844, 817, 745, 696, 665.

5k: 2,3,5-Tri-O-benzyl-d-ribofuranosyl picolinate.

To an oven-dried flask was added commercially available 2,3,5-tri-O-benzyl-d-ribofuranose (1.00 mmol, 420.5 mg), DMAP (0.20 mmol, 24.4 mg), picolinate acid (1.30 mmol, 160.0 mg), EDCI (2.00 mmol, 383.3 mg) and dry DCM (5.0 mL) under Ar. The reaction was stirred at RT and monitored by TLC. After the reaction was completed (~12 h), the solvent was removed under vacuum and the residue was purified by flash column chromatography (eluent: Hex:EA=5:1, V/V) to afford 5k (α:β=2.2:1, light yellow syrup, 430.0 mg, 82% yield). Reported as mixture of anomers, ratio identified through 1H NMR spectroscopy. Optical rotation: [α]D21 = +30.9 (c 1.14, CHCl3). 1H NMR (400 MHz, CDCl3, TMS) δ 8.86 – 8.69 (m, 2H), 8.06 (dd, J = 29.2, 7.7 Hz, 2H), 7.84 (m, 2H), 7.64 (td, J = 7.7, 1.8 Hz, 2H), 7.55 – 7.23 (m, 30H), 6.55 (s, 1H), 6.38 (d, J = 7.3 Hz, 1H), 5.02 – 4.84 (m, 2H), 4.83 – 4.43 (m, 8H), 4.41 – 4.31 (m, 2H), 4.26 – 4.07 (m, 2H), 3.92 (dd, J = 11.1, 4.6 Hz, 1H), 3.83 (dd, J = 11.1, 3.1 Hz, 1H), 3.77 – 3.62 (m, 3H). 13C{1H}NMR (101 MHz, CDCl3, TMS) δ 163.7, 163.7, 163.4, 150.1, 150.0, 147.6, 147.5, 139.1, 138.7, 138.2, 138.1, 138.0, 137.9, 137.6, 137.6, 137.4, 136.9, 136.9, 136.9, 128.5, 128.5, 128.5, 128.4, 128.3, 128.3, 128.2, 128.2, 128.0, 127.9, 127.9, 127.9, 127.8, 127.8, 127.7, 127.7, 127.6, 127.6, 127.5, 127.5, 127.4, 127.1, 127.0, 126.8, 126.4, 125.5, 125.4, 100.5, 94.0, 89.9, 81.9, 78.7, 75.2, 74.7, 74.5, 74.5, 74.2, 73.8, 73.3, 72.5, 72.2, 71.6, 71.2, 69.6, 63.2, 58.9. HRMS (ESI) for C32H31NO6 (M+Na), 548.2044 (Calc.), found 548.2040. IR (neat): ν 1736, 1585, 1496, 1454, 1361, 1305, 1284, 1244, 1216, 1071, 1027, 995, 925, 821, 745, 696, 666.

5n: 2,3,4-Tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α-d-glucopyranosyl)-d-glucopyranosyl picolinate.

To an oven-dried flask was added commercially available 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α-d-glucopyranosyl)-d-glucopyranose (1.00 mmol, 973.2 mg), DMAP (0.20 mmol, 24.4 mg), picolinate acid (1.30 mmol, 160.0 mg), EDCI (2.00 mmol, 383.3 mg) and dry DCM (5.0 mL) under Ar. The reaction was stirred at RT and monitored by TLC. After the reaction was completed (~12 h), the solvent was removed under vacuum and the residue was purified by flash column chromatography (eluent: Hex:EA=5:1, V/V) to afford 5n (α:β=1.4:1, colorless syrup, 260.0 mg, 78% yield). Reported as mixture of anomers, ratio identified through 1H NMR spectroscopy. Optical rotation: [α]D21 = +52.5 (c 1.01, CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.83 – 8.68 (m, 2H), 8.12 (d, J = 7.8 Hz, 1H), 8.04 (d, J = 7.8 Hz, 1H), 7.78 (td, J = 7.8, 1.7 Hz, 1H), 7.69 (td, J = 7.8, 1.7 Hz, 1H), 7.47 – 7.34 (m, 2H), 7.37 – 7.04 (m, 70H), 6.70 (d, J = 3.6 Hz, 1H), 6.04 (d, J = 6.9 Hz, 1H), 5.78 (d, J = 3.5 Hz, 1H), 5.67 (d, J = 3.6 Hz, 1H), 5.06 (d, J = 11.7 Hz, 1H), 4.96 – 4.78 (m, 12H), 4.71 (d, J = 11.3 Hz, 2H), 4.66 – 4.42 (m, 12H), 4.32 – 4.16 (m, 8H), 4.03 – 3.75 (m, 8H), 3.74 – 3.64 (m, 2H), 3.59 – 3.49 (m, 2H), 3.47 – 3.34 (m, 3H). 13C{1H}NMR (101 MHz, CDCl3) δ 163.7, 163.6, 150.3, 150.2, 147.7, 147.4, 138.9, 138.9, 138.7, 138.5, 138.4, 138.3, 138.2, 138.1, 138.0, 138.0, 137.9, 137.5, 137.0, 128.5, 128.5, 128.5, 128.4, 128.4, 128.3, 128.3, 128.2, 128.2, 128.1, 128.1, 128.0, 1278.0, 127.9, 127.9, 127.8, 127.8, 127.8, 127.7, 127.7, 127.6, 127.6, 127.5, 127.4, 127.3, 127.3, 126.9, 126.8, 125.7, 125.6, 97.1, 97.1, 95.2, 91.3, 84.9, 82.1, 81.8, 80.7, 79.6, 79.5, 79.4, 77.8, 75.7, 75.2, 75.1, 74.8, 74.5, 74.2, 73.6, 73.6, 73.5, 73.5, 73.4, 73.4, 73.3, 73.1, 72.8, 71.9, 71.2, 71.2, 68.9, 68.6, 68.3. HRMS (ESI) for C67H67NO12 (M+Na), 1100.4561 (Calc.), found 1100.4561. IR (neat): ν 1738, 1585, 1496, 1454, 1362, 1303, 1289, 1244, 1214, 1152, 1069, 1041, 1027, 914, 849, 819, 744, 735, 696, 665.

General procedure for the synthesis of C-glycosides with allyl TMS.

Condition A: Picolinic ester (0.10 mmol), Cu(OTf)2 (1.2 eq, dried under vacuum overnight), and 4Å MS (about 100.0 mg, dried with hot gun under vacuum for 15 min) were added to a vial. Then the vial was refilled with Argon. CH2Cl2 (0.5 mL) and allyl TMS (6.0 equiv) were added with syringes under Argon. The vial was capped and stirred at rt for 12-30 h until TLC analysis showed the picolinate was completely converted, usually 16 h. The mixture was purified through a silica gel column chromatography (Hexane/Ethyl acetate = 10:1) to give the corresponding C-glycosides. Condition B: Picolinic ester (0.10 mmol) and toluene (0.30 mL, as the azeotrope to remove water) were added to 3 mL vial. The mixture was stirred under vacuum to remove toluene and the operation was repeated 3 times for removing water as much as possible. Then dried Cu(OTf)2 (1.2 equiv) was added to the vial and the vial was refilled with Argon. CH2Cl2 (0.5 mL) and allyl TMS (6.0 equiv) were added with syringes under Argon. The vial was capped and stirred at rt for 12-30 h until TLC analysis showed the picolinate was completely converted, usually 16 h. The mixture was purified through a silica gel column chromatography (Hexane/Ethyl acetate = 10:1) to give the corresponding C-glycosides.

7a: 3-(Tetra-O-benzyl-α-d-galactopyranosyl)-prop-1-ene.

Condition A was used to synthesize compound 7a. Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 7a (α, colorless oil, 53.0 mg, 95% yield; β, colorless oil, 2.5 mg, 4% yield). Spectral data are in accordance with the literature.24

7e: 3-(2,3,4,6-Tetra-O-benzyl-α-d-glucopyranosyl)-prop-1-ene.

Condition A was used to synthesize compound 7e. Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 7e (α, colorless oil, 51.0 mg, 90% yield; β, colorless oil, 2.0 mg, 4% yield). Spectral data are in accordance with the literature.25 The one mmol scale reaction was performed following the same procedure. Picolinic ester 5e (645.8 mg, 1.00 mmol), Cu(OTf)2 (434.0 mg, 1.20 mmol), and activated 4Å MS (600.0 mg) were added to a 25 mL round bottom flask. Then the flask was refilled with Argon. CH2Cl2 (3.0 mL) and allyl TMS (685.6 mg, 6.00 mmol) were added with syringes under Argon. The reaction mixture was stirred at rt for 17 h before it was filtered through a pad of Celite. The filtrate was concentrated under reduced pressure. Flash column chromatography (eluent: Hex:EA=10:1, V/V) afford 7e as a colorless oil (484.6 mg, 86% yield, α:β=15:1).

7f: 3-(2,3,4,6-Tetra-O-benzyl-α-d-mannopyranosyl)-prop-1-ene.

Condition A was used to synthesize compound 7f. Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 7f (α:β=10:1, colorless oil, 55.0 mg, 98% total yield). Spectral data are in accordance with the literature.25

7g: 3-(2,3,4-Tri-O-benzyl-d-xylopyranosyl)-prop-1-ene.

Condition B was used to synthesize compound 7g. Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 7g (α, colorless oil, 33.0 mg, 74% yield; α:β=10:1). The α isomer: Optical rotation: [α]D21 = +12.6 (c 0.170, CHCl3). 1H NMR (400 MHz, CDCl3, TMS) δ 7.41 – 7.27 (m, 15H), 5.77 (ddt, J = 17.1, 10.2, 6.9 Hz, 1H), 5.13 – 4.99 (m, 2H), 4.65 (d, J = 11.9 Hz, 1H), 4.59 (d, J = 7.7 Hz, 4H), 4.51 (d, J = 11.8 Hz, 1H), 3.83 – 3.67 (m, 4H), 3.42 (dd, J = 5.3, 3.7 Hz, 2H), 2.60 – 2.48 (m, 1H), 2.36 (m, 1H). 13C{1H}NMR (101 MHz, CDCl3, TMS) δ 138.3, 138.3, 135.0, 128.4, 128.4, 128.3, 128.1, 127.9, 127.8, 127.7, 127.7, 116.9, 77.2, 76.4, 75.2, 74.9, 74.8, 73.4, 72.6, 72.1, 64.5, 33.0, 29.7. HRMS (ESI) for C29H32O4 (M+Na), 467.2193 (Calc.), found 467.2187. IR (neat): ν 1496, 1454, 1421, 1395, 1361, 1325, 1301, 1280, 1253, 1209, 1087, 1027, 1003, 992, 973, 935, 912, 873, 848, 828, 807, 796, 751, 737, 697, 679.

7h: 3-(2,3,4-Tri-O-benzyl-α-l-fucopyranosyl)-prop-1-ene.

Condition B was used to synthesize compound 7h. Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 7h (α, colorless oil, 30.0 mg, 65% yield; α:β=20:1). Spectral data are in accordance with the literature.26

7i: 3-(3,4,6-Tri-O-benzyl-2-deoxy-d-glucopyranosyl)-prop-1-ene.

Condition B was used to synthesize compound 7i. Crude product purified via flash column chromatography (eluent: CH2Cl2:Acetone=50:1, V/V) to afford 7i (only α, colorless oil, 24.0 mg, 53% yield). Spectral data are in accordance with the literature.27

7j: 3-(3,4,6-Tri-O-benzyl-2-deoxy-α-d-galactopyranosyl)-prop-1-ene.

Condition B was used to synthesize compound 7j. Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 7j (only α, colorless oil, 31.0 mg, 68% yield). Spectral data are in accordance with the literature.16

7k: 3-(2,3,5-Tri-O-benzyl-α-d-ribofuranosyl)-prop-1-ene.

Condition B was used to synthesize compound 7k. Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 7k (only α, colorless oil, 26.0 mg, 59% yield). Spectral data are in accordance with the literature.28

7l: 2,3-Di-O-benzyl-4,6-O-benzylidene-1-deoxy-1-allyl-d-glucopyranose.

Condition A was used to synthesize compound 7l. Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 7l (α, white solid, 38.0 mg, 81% yield; α:β=20:1). Spectral data are in accordance with the literature.18a

7m: 2,3-Di-O-benzyl-4,6-O-benzylidene-1-deoxy-1-allyl-α-d-mannopyranose.

Condition A was used to synthesize compound 7m. Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 7m (only α, colorless oil, 25.0 mg, 53% yield). Spectral data are in accordance with the literature.18a

7n: 2,3,4-Tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α-d-glucopyranosyl)-1-deoxy-1-allyl-d-glucopyranose.

Condition A was used to synthesize compound 7n. Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 7n (α, colorless oil, 60.0 mg, 69% yield; α:β=8:1, 0.09 mmol scale). The α isomer: Optical rotation: [α]D21 = +41.2 (c 0.425, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.32 – 7.14 (m, 33H), 7.10 (dd, J = 6.9, 2.7 Hz, 2H), 5.88 – 5.73 (m, 1H), 5.57 (d, J = 3.6 Hz, 1H), 5.20 – 5.00 (m, 2H), 4.87 (dd, J = 11.3, 8.2 Hz, 2H), 4.80 – 4.71 (m, 3H), 4.64 – 4.39 (m, 8H), 4.28 (d, J = 12.2 Hz, 1H), 4.10 (dt, J = 10.3, 4.8 Hz, 1H), 4.02 (t, J = 8.3 Hz, 1H), 3.95 – 3.86 (m, 2H), 3.82 – 3.72 (m, 4H), 3.69 – 3.61 (m, 2H), 3.55 – 3.47 (m, 2H), 3.40 (dd, J = 10.8, 2.0 Hz, 1H), 2.61 – 2.49 (m, 1H), 2.49 – 2.39 (m, 1H). 13C{1H}NMR (101 MHz, CDCl3) δ 138.8, 138.8, 138.5, 138.5, 138.1, 138.1, 138.0, 134.8, 128.4, 128.4, 128.3, 128.3, 128.3, 128.2, 128.1, 127.9, 127.87, 127.85, 127.8, 127.8, 127.7, 127.7, 127.6, 127.5, 127.4, 127.3, 127.3, 126.9, 117.0, 96.9, 82.0, 81.4, 79.6, 79.5, 77.8, 75.5, 75.0, 73.6, 73.5, 73.4, 73.2, 73.0, 72.7, 71.2, 71.0, 69.6, 68.2, 30.7. HRMS (ESI) for C64H68O10 (M+Na), 1019.4705 (Calc.), found 1019.4681. IR (neat): ν 1497, 1454, 1360, 1215, 1074, 1027, 916, 745, 697, 666.

7o: 1,5-Anhydro-2,3,4-tri-O-benzoyl-d-threo-pent-1-enitol.

Condition A was used to synthesize compound 7o. Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 7o (white solid, 30.0 mg, 68% yield). Spectral data are in accordance with the literature.29

General procedure for the synthesis of C-glycosides with silyl enol ethers.

Picolinic ester (0.10 mmol), Cu(OTf)2 (1.2 eq, dried under vacuum overnight), and 4Å MS (about 100.0 mg, dried with hot gun under vacuum for 15 min) were added to a vial. Then the vial was refilled with Argon. CH2Cl2 (0.5 mL) and silyl enol ether (1.5 equiv) were added with syringes under Argon. The vial was capped and stirred at rt for 12-30 h until TLC analysis showed the picolinate was completely converted, usually 16 h. The mixture was purified through a silica gel column chromatography (Hexane/Ethyl acetate=10:1) to give the corresponding C-glycosides.

9a: 1-(2,3,4,6-Tetra-O-benzyl-d-galactopyranosyl)-acetophenone.

Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 9a (α:β=2.7:1, colorless oil, 60.0 mg, 93% total yield). Spectral data are in accordance with the literature.30

9b: 1-(2,3,4,6-Tetra-O-benzyl-α-d-glucopyranosyl)-acetophenone.

Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 9b (only α, white solid, 58.0 mg, 90% yield). Spectral data are in accordance with the literature.16 The 1.0 mmol scale reaction was performed following the same procedure. Picolinic ester 5e (645.8 mg, 1.00 mmol), Cu(OTf)2 (434.0 mg, 1.20 mmol), and activated 4Å MS (600.0 mg) were added to a 25 mL round bottom flask. Then the flask was refilled with Argon. CH2Cl2 (5.0 mL) and silyl enol ether 8a (288.5 mg, 1.50 mmol) were added with syringes under Argon. The reaction mixture was stirred at rt for 7 h before it was filtered through a pad of Celite. The filtrate was concentrated under reduced pressure. Flash column chromatography (eluent: Hex:EA=10:1, V/V) afford 9b as a white solid (567.9 mg, 88% yield, only α).

9c: 1-(2,3,4,6-Tetra-O-benzyl-d-mannopyranosyl)-acetophenone.

Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 9c (α:β=1.7:1, colorless oil, 63.0 mg, 98% total yield). A small portion of the anomers was separated. The α isomer: Optical rotation: [α]D21 = +5.26 (c 0.570, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 8.1 Hz, 2H), 7.54 (t, J = 7.4 Hz, 1H), 7.43 (t, J = 7.6 Hz, 2H), 7.37 – 7.17 (m, 20H), 4.78 – 4.71 (m, 1H), 4.65 (dd, J = 11.5, 1.5 Hz, 1H), 4.61 – 4.39 (m, 7H), 3.91 – 3.84 (m, 2H), 3.84 – 3.76 (m, 3H), 3.76 – 3.72 (m, 1H), 3.21 (td, J = 6.5, 1.5 Hz, 2H). 13C{1H}NMR (101 MHz, CDCl3) δ 197.6, 138.4, 138.2, 138.1, 138.1, 137.0, 133.1, 128.6, 128.4, 128.3, 128.3, 128.2, 128.1, 128.0, 127.8, 127.8, 127.7, 127.5, 76.0, 75.3, 74.6, 73.5, 73.4, 71.9, 71.2, 69.1, 68.8, 39.8. HRMS (ESI) for C42H42O6 (M+Na), 665.2874 (Calc.), found 665.2857. IR (neat): ν 1682, 1598, 1496, 1453, 1362, 1216, 1093, 1026, 913, 863, 846, 814, 746, 696, 666.

9d: 2,3-Di-O-benzyl-4,6-O-benzylidene-1-(2-oxo-2-phenylethyl)-d-glucopyranose.

Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 9d (α:β=7:1, colorless oil, 43.0 mg, 78% total yield). Spectral data are in accordance with the literature.18b

9e: 2,3-Di-O-benzyl-4,6-O-benzylidene-1-deoxy-1-(2-oxo-2-phenylethyl)-d-mannopyranose.

Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 9e (α:β=1:13, colorless oil, 28.0 mg, 51% total yield). Spectral data are in accordance with the literature.18b

9f: 3,3-Dimethyl-1-(2,3,4,6-tetra-O-benzyl-d-galactopyranosyl)-butan-2-one.

Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 9f (α:β=4.5:1, colorless oil, 57.0 mg, 92% total yield). Reported as mixture of anomers, ratio identified through 1H NMR spectroscopy. Optical rotation: [α]D21 = +16.1 (c 0.410, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.15 (m, 40H), 4.94 (dd, J = 17.3, 11.6 Hz, 2H), 4.77 – 4.72 (m, 1H), 4.69 – 4.60 (m, 7H), 4.58 – 4.35 (m, 8H), 4.08 – 4.00 (m, 2H), 3.98 (dd, J = 4.3, 2.8 Hz, 1H), 3.92 – 3.83 (m, 2H), 3.81 (dd, 1H), 3.74 – 3.64 (m, 4H), 3.61– 3.44 (m, 2H), 2.85 – 2.63 (m, 3H), 2.56 (dd, J = 16.8, 2.2 Hz, 1H), 1.07 (s, 9H), 1.03 (s, 9H). 13C{1H}NMR (101 MHz, CDCl3) δ 213.2, 213.1, 138.8, 138.5, 138.5, 138.4, 138.3, 138.1, 138.0, 128.4, 128.4, 128.4, 128.3, 128.2, 128.2, 128.1, 127.9, 127.8, 127.8, 127.7, 127.7, 127.6, 127.5, 85.0, 77.6, 77.2, 76.9, 76.2, 75.7, 75.6, 74.9, 74.7, 74.0, 73.8, 73.4, 73.3, 73.2, 72.8, 72.7, 72.2, 68.7, 67.3, 67.2, 44.2, 44.1, 39.0, 35.8, 29.7, 26.3, 26.1. HRMS (ESI) for C40H46O6 (M+Na), 645.3187 (Calc.), found 645.3173. IR (neat): ν 1704, 1496, 1454, 1367, 1216, 1092, 1028, 911, 746, 696, 667.

9g: 3,3-Dimethyl-1-(2,3,4,6-tetra-O-benzyl-α-d-glucopyranosyl)-butan-2-one.

Crude product purified via flash column chromatography (eluent: Hex:EA=10:1, V/V) to afford 9g15b (α:β > 20:1, white solid, 54.0 mg, 87% yield). Spectral data are in accordance with the literature.31

Supplementary Material

Supporting Information

ACKNOWLEDGMENT

We thank the University of Wisconsin-Madison and NIH (U01 GM125290) for financial support.

Footnotes

ASSOCIATED CONTENT

Supporting Information.

This material is available free of charge via the Internet at http://pubs.acs.org
Copies of 1H NMR data
Copies of 13C{1H}NMR data

REFERENCES

  • (1).(a) Demchenko AV Handbook of Chemical Glycosylation: Advances in Stereoselectivity and Therapeutic Relevance; WILEY-VCH Verlag GmbH & Co. KGaA: Weinheim, 2008; [Google Scholar]; (b) Ranade SC; Demchenko AV Mechanism of Chemical Glycosylation: Focus on the Mode of Activation and Departure of Anomeric Leaving Groups. J. Carbohydr. Chem 2013, 32, 1; [Google Scholar]; (c) Yao H; Vu MD; Liu XW Recent Advances in Reagent-Controlled Stereoselective/Stereospecific Glycosylation. Carbohydr. Res 2019, 473, 72. and references cited therein. [DOI] [PubMed] [Google Scholar]
  • (2).(a) Yang Y; Yu B Recent Advances in the Chemical Synthesis of C-Glycosides. Chem. Rev 2017, 117, 12281; [DOI] [PubMed] [Google Scholar]; (b) Bokor E; Kun S; Goyard D; Toth M; Praly JP; Vidal S; Somsak L C-Glycopyranosyl Arenes and Hetarenes: Synthetic Methods and Bioactivity Focused on Antidiabetic Potential. Chem. Rev 2017, 117, 1687; [DOI] [PubMed] [Google Scholar]; (c) Liao HZ; Ma JM; Yao H; Liu XW Recent Progress of C-Glycosylation Methods in the Total Synthesis of Natural Products and Pharmaceuticals. Org. Biomol. Chem 2018, 16, 1791. [DOI] [PubMed] [Google Scholar]
  • (3).(a) Yang GL; Schmieg J; Tsuji M; Franck RW The C-Glycoside Analogue of the Immunostimulant Alpha-Galactosylceramide (Krn7000): Synthesis and Striking Enhancement of Activity. Angew. Chem. Int. Ed 2004, 43, 3818; [DOI] [PubMed] [Google Scholar]; (b) Franck RW; Tsuji M Alpha-C-Galactosylceramides: Synthesis and Immunology. Acc. Chem. Res 2006, 39, 692. [DOI] [PubMed] [Google Scholar]
  • (4).Gruca A; Krawczyk Z; Szeja W; Grynkiewicz G; Rusin A Synthetic Genistein Glycosides Inhibiting EGFR Phosphorylation Enhance the Effect of Radiation in HCT 116 Colon Cancer Cells. Molecules 2014, 19, 18558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (5).(a) Ghosh S; Pradhan TK Stereoselective Total Synthesis of (+)-Varitriol, (−)-Varitriol, 5 ’-Epi-(+)-Varitriol, and 4 ’-Epi-(−)-Varitriol from D-Mannitol. J. Org. Chem 2010, 75, 2107; [DOI] [PubMed] [Google Scholar]; (b) Zeng J; Vedachalam S; Xiang SH; Liu XW Direct C-Glycosylation of Organotrifluoroborates with Glycosyl Fluorides and Its Application to the Total Synthesis of (+)-Varitriol. Org. Lett 2011, 13, 42. [DOI] [PubMed] [Google Scholar]
  • (6).Liu P; Jacobsen EN Total Synthesis of (+)-Ambruticin. J. Am. Chem. Soc 2001, 123, 10772. [DOI] [PubMed] [Google Scholar]
  • (7).(a) Wei XF; Shi SL; Xie XW; Shimizu Y; Kanai M Copper(I)-Catalyzed Dehydrative C-Glycosidation of Unprotected Pyranoses with Ketones. Acs Catalysis 2016, 6, 6718; [Google Scholar]; (b) Johnson S; Bagdi AK; Tanaka F C-Glycosidation of Unprotected Di- and Trisaccharide Aldopyranoses with Ketones Using Pyrrolidine-Boric Acid Catalysis. J. Org. Chem 2018, 83, 4581. [DOI] [PubMed] [Google Scholar]
  • (8).Liu L; Motaal BA; Schmidt-Supprian M; Pohl NLB Multigram Synthesis of Isobutyl-Beta-C-Galactoside as a Substitute of Isopropylthiogalactoside for Exogenous Gene Induction in Mammalian Cells. J. Org. Chem 2012, 77, 1539. [DOI] [PubMed] [Google Scholar]
  • (9).(a) Ng K; Shaktah R; Vardanyan L; Minehan TG Total Synthesis of Alvaradoins E and F, Uveoside, and 10-Epi-Uveoside. Org. Lett 2019, 21, 9175; [DOI] [PubMed] [Google Scholar]; (b) Du YG; Linhardt RJ; Vlahov IR Recent Advances in Stereoselective C-Glycoside Synthesis. Tetrahedron 1998, 54, 9913. [Google Scholar]
  • (10).Beau JM; Gallagher T In Glycoscience Synthesis of Substrate Analogs and Mimetics; Driguez H, Thiem J, Eds. 1997; Vol. 187, p 1. [Google Scholar]
  • (11).(a) Liu Z; Bittman R Synthesis of C-Glycoside Analogues of Alpha-Galactosylceramide Via Linear Allylic C-H Oxidation and Allylic Cyanate to Isocyanate Rearrangement. Org. Lett 2012, 14, 620; [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Krumper JR; Salamant WA; Woerpel KA Correlations between Nucleophilicities and Selectivities in the Substitutions of Tetrahydropyran Acetals. J. Org. Chem 2009, 74, 8039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (12).Wang HY; Simmons CJ; Blaszczyk SA; Balzer PG; Luo RS; Duan XY; Tang WP Isoquinoline-1-Carboxylate as a Traceless Leaving Group for Chelation-Assisted Glycosylation under Mild and Neutral Reaction Conditions. Angew. Chem. Int. Ed 2017, 56, 15698. [DOI] [PubMed] [Google Scholar]
  • (13).(a) Koide K; Ohno M; Kobayashi S A New Glycosylation Reaction Based on a Remote Activation Concept - Glycosyl 2-Pyridinecarboxylate as a Novel Glycosyl Donor. Tetrahedron Lett. 1991, 32, 7065; [Google Scholar]; (b) Furukawa H; Koide K; Takao K; Kobayashi S Glycosyl 2-Pyridinecarboxylate as an Effective Glycosyl Donor: Glycosidation of Mannose, 2-Azidosugar, and 2-Deoxysugar into Disaccharides. Chem. Pharm. Bull 1998, 46, 1244. [Google Scholar]
  • (14).(a) Hanessian S; Bacquet C; Lehong N Chemistry of the Glycosidic Linkage - Exceptionally Fast and Efficient Formation of Glycosides by Remote Activation. Carbohydr. Res 1980, 80, C17; [Google Scholar]; (b) Hanessian S; Lou BL Stereocontrolled Glycosyl Transfer Reactions with Unprotected Glycosyl Donors. Chem. Rev 2000, 100, 4443; [DOI] [PubMed] [Google Scholar]; (c) Mukaiyama T; Nakatsuka T; Shoda SI Efficient Glucosylation of Alcohol Using 1-Thioglucoside Derivative. Chem. Lett 1979, 487. [Google Scholar]
  • (15).(a) Lewis MD; Cha JK; Kishi Y Highly Stereoselective Approaches to Alpha-C-Glycopyranoside and Beta-C-Glycopyranoside. J. Am. Chem. Soc 1982, 104, 4976; [Google Scholar]; (b) Bennek JA; Gray GR An Efficient Synthesis of Anhydroalditols and Allyl C-Glycosides. J. Org. Chem 1987, 52, 892; [Google Scholar]; (c) Hosomi A; Sakata Y; Sakurai H Stereoselective Synthesis of 3-(D-Glycopyranosyl)Propenes by Use of Allylsilanes. Carbohydr. Res 1987, 171, 223. [Google Scholar]
  • (16).Chen XP; Wang QL; Yu B Gold(I)-Catalyzed C-Glycosylation of Glycosyl Ortho-Alkynylbenzoates: The Role of the Moisture Sequestered by Molecular Sieves. Chem. Commun 2016, 52, 12183. [DOI] [PubMed] [Google Scholar]
  • (17).(a) McGarvey GJ; LeClair CA; Schmidtmann BA Studies on the Stereoselective Synthesis of C-Allyl Glycosides. Org. Lett 2008, 10, 4727; [DOI] [PubMed] [Google Scholar]; (b) Neralkar M; Mishra B; Hotha S Nucleofuge Generating Glycosidations by the Remote Activation of Hydroxybenzotriazolyl Glycosides. J. Org. Chem 2017, 82, 11494; [DOI] [PubMed] [Google Scholar]; (c) Ling J; Bennett CS Versatile Glycosyl Sulfonates in Beta-Selective C-Glycosylation. Angew. Chem. Int. Ed 2020, 59, 4304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (18).(a) Crich D; Sharma I Is Donor-Acceptor Hydrogen Bonding Necessary for 4,6-O-Benzylidene-Directed Beta-Mannopyranosylation? Stereoselective Synthesis of Beta-C-Mannopyranosides and Alpha-C-Glucopyranosides. Org. Lett 2008, 10, 4731; [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Moume-Pymbock M; Crich D Stereoselective C-Glycoside Formation with 2-O-Benzyl-4,6-O-Benzylidene Protected 3-Deoxy Gluco- and Mannopyranoside Donors: Comparison with O-Glycoside Formation. J. Org. Chem 2012, 77, 8905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (19).Wen P; Simmons CJ; Ma ZX; Blaszczyk SA; Balzer PG; Ye WJ; Duan XY; Wang HY; Yin D; Stevens CM; Tang W Synthesis of Glycosyl Chlorides and Bromides by Chelation Assisted Activation of Picolinic Esters under Mild Neutral Conditions. Org. Lett 2020, 22, 1495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (20).Lucero CG; Woerpel KA Stereoselective C-Glycosylation Reactions of Pyranoses: The Conformational Preference and Reactions of the Mannosyl Cation. J. Org. Chem 2006, 71, 2641. [DOI] [PubMed] [Google Scholar]
  • (21).(a) Mukaiyama T; Murakami M Cross-Coupling Reactions Based on Acetals. Synthesis 1987, 1043; [Google Scholar]; (b) Araki Y; Kobayashi N; Ishido Y; Nagasawa J Synthetic Studies by the Use of Fluorinated Intermediates .3. Highly Stereoselective C-Alpha-D-Ribofuranosylation - Reactions of D-Ribofuranosyl Fluoride Derivatives with Enol Trimethylsilyl Ethers and with Allyltrimethylsilane. Carbohydr. Res 1987, 171, 125; [Google Scholar]; (c) Mahrwald R Diastereoselection in Lewis-Acid-Mediated Aldol Additions. Chem. Rev 1999, 99, 1095. [DOI] [PubMed] [Google Scholar]
  • (22).Moorthy JN; Samanta S; Koner AL; Saha S; Nau WM Intramolecular O-H-O Hydrogen-Bond-Mediated Reversal in the Partitioning of Conformationally Restricted Triplet 1,4-Biradicals and Amplification of Diastereodifferentiation in Their Lifetimes. J. Am. Chem. Soc 2008, 130, 13608. [DOI] [PubMed] [Google Scholar]
  • (23).Esumi N; Suzuki K; Nishimoto Y; Yasuda M Synthesis of 1,4-Dicarbonyl Compounds from Silyl Enol Ethers and Bromocarbonyls, Catalyzed by an Organic Dye under Visible-Light Irradiation with Perfect Selectivity for the Halide Moiety over the Carbonyl Group. Org. Lett 2016, 18, 5704. [DOI] [PubMed] [Google Scholar]
  • (24).Fletcher S; Jorgensen MR; Miller AD Facile Preparation of an Orthogonally Protected, Ph-Sensitive, Bioconjugate Linker for Therapeutic Applications. Org. Lett 2004, 6, 4245. [DOI] [PubMed] [Google Scholar]
  • (25).Miller GJ; Gardiner JM Adaptable Synthesis of C-Glycosidic Multivalent Carbohydrates and Succinamide-Linked Derivatization. Org. Lett 2010, 12, 5262. [DOI] [PubMed] [Google Scholar]
  • (26).Uchiyama T; Woltering TJ; Wong WC; Lin CC; Kajimoto T; Takebayashi M; WeitzSchmidt G; Asakura T; Noda M; Wong CH Design and Synthesis of C-Linked Fucosides as Inhibitors of E-Selectin. Bioorg. Med. Chem 1996, 4, 1149. [DOI] [PubMed] [Google Scholar]
  • (27).Wang Z; Shao HW; Lacroix E; Wu SH; Jennings HJ; Zou W Epimerization of 2 ’-Carbonylalkyl-C-Glycosides Via Enolation, Beta-Elimination and Intramolecular Cycloaddition. J. Org. Chem 2003, 68, 8097. [DOI] [PubMed] [Google Scholar]
  • (28).Mukaiyama T; Kobayashi S A Convenient Synthesis of C-Alpha-D-Ribofuranosyl Compounds from 1-O-Acetyl-2,3,5-Tri-O-Benzyl-Beta-D-Ribose by the Promotion of Triphenylmethyl Perchlorate. Carbohydr. Res 1987, 171, 81. [Google Scholar]
  • (29).Crich D; Dai ZM; Gastaldi S On the Role of Neighboring Group Participation and Ortho Esters in Beta-Xylosylation: C-13 Nmr Observation of a Bridging 2-Phenyl-1,3-Dioxalenium Ion. J. Org. Chem 1999, 64, 5224. [DOI] [PubMed] [Google Scholar]
  • (30).Massi A; Nuzzi A; Dondoni A Microwave-Assisted Organocatalytic Anomerization of Alpha-C-Glycosylmethyl Aldehydes and Ketones. J. Org. Chem 2007, 72, 10279. [DOI] [PubMed] [Google Scholar]
  • (31).Schmidt RR; Hoffmann M Glycosyl Imidates .7. Synthesis of C-Alpha-D-Glucopyranosyl and C-Beta-D-Glucopyranosyl Derivatives from O-(Alpha-D-Glucopyranosyl) Trichloroacetimidate. Angew. Chem. Int. Ed 1983, 22, 406. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES